The Foundation for Peripheral Neuropathy (FPN) is pleased to announce the 2026-28 cycle of our early career research grants, offered through the American Academy of Neurology (AAN) and American Brain Foundation (ABF). This grant is called the Clinical Research Training Scholarship in Peripheral Neuropathy (CRTS in PN). The goal of this funding mechanism is to […]
The Peripheral Nerve Society (PNS) is a global non-profit group made up of doctors, scientists, and healthcare workers. They study and treat diseases of the peripheral nervous system. Each year, the PNS hosts the PNS Annual Meeting. This event brings experts from around the world to share the newest research about peripheral nerve diseases. It’s […]
Read More… from Learn About the Latest in Peripheral Nerve Research
For the fourth consecutive year, peripheral neuropathy (PN) has been renewed for research funding by the Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP)’s $150 million fund for FY25. In advance of pre-application deadlines, we are sharing the FY25 funding mechanisms, award amounts, maximum direct costs and how to apply. Want to learn more about […]
For the first time, we organized Neuropathy Advocacy Day and took our message directly to Congress. On March 18, 2025, staff and board members from the Foundation traveled to Washington, D.C. to speak up for the 30 million Americans who have peripheral neuropathy (PN). Our visit was urgent because earlier this month, Congress passed a […]
Peripheral neuropathy (PN) is vastly under-researched, despite its prevalence. While over 30 million Americans live with PN, the National Institutes of Health (NIH) funded less than $200 million in PN research from its $47 billion annual budget in 2024. That is less than $7 per PN patient. Neurological conditions are now the leading cause of […]
Read More… from Advocating for PN research: the critical need for research dollars
Our bodies have an incredible internal control system called the autonomic nervous system (ANS). It keeps essential functions—like heart rate, blood pressure, breathing, and digestion—running smoothly without us even thinking about it. But when this system doesn’t work as it should, the results can be life-altering, especially for people with diseases like diabetes, amyloidosis, or peripheral neuropathy […]
Paula Barreras, MD, neuroimmunology fellow at Johns Hopkins Hospital, was one of the first recipients of the Foundation for Peripheral Neuropathy’s (FPN) Clinical Research Training Scholarships (CRTS). Through these awards, FPN is supporting early-career researchers in peripheral neuropathy. Did you know that about 40% of people with sarcoidosis, an inflammatory disease, also experience a nerve condition called small fiber neuropathy (SFN)? […]
Attracting and retaining top research talent is vital to improving therapies for peripheral neuropathy. Some of the brightest researchers are often drawn to well-known disciplines with the largest funding pools – such as cancer research. To combat this challenge, FPN works in partnership with the American Brain Foundation and the American Academy of Neurology to facilitate a Clinical Research Training Scholarship (CRTS). […]
Read More… from Clinical Research Training Scholarship Update
Registry’s New Research Findings on Vitamin D The Foundation for Peripheral Neuropathy (FPN) started the Peripheral Neuropathy Research Registry (PNRR) in 2008. The PNRR collects data and samples (like blood and DNA) from people living with peripheral neuropathy (PN), a condition that affects the nerves and can cause pain and other issues. Why the PNRR Matters Peripheral neuropathy (PN) has many […]
Read More… from Registry’s New Research Findings on Vitamin D
As this side of the hemisphere welcomes in the warm, summer weather, we at the Foundation for Peripheral Neuropathy encourage our patients to take advantage by taking daily walks, purchasing (or even growing!) fresh produce, and soaking up some vitamin D! We hope you find this issue to inspire you to enjoy nature and make some healthy decisions. […]